Document is current
Any future updates will be listed below
-
Authors
Ono, Tomohiro
Uto, Megumi
Mineharu, Yohei
Arakawa, Yoshiki
Nakamura, Mitsuhiro
Nishio, Teiji
Igaki, Hiroshi
Nihei, Keiji
Ishikura, Satoshi
Narita, Yoshitaka
Mizowaki, Takashi
,
-
Funding
Funding for this research was provided by:
Japanese National Cancer Center Research and Development Fund (2020-J-3 and 2023-J-3)
the Japan Agency for Medical Research and Development (JP20ck0106619)
- License Information
-
More Information
Article History
Received: 2 October 2024
Accepted: 23 February 2025
First Online: 9 March 2025
Declarations
:
: This study is being conducted in accordance with the principles expressed in the Declaration of Helsinki, Clinical Trials Act (Act No. 16 of April 14, 2017) and SPRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines. The protocol for this study was approved by the JCOG Protocol Review Committee on April 24, 2020, and by the National Cancer Center Hospital Certified Review Board on June 25, 2020 (CRB3180008). Written informed consent has been obtained from all enrolled participants.
: Not applicable.
: The authors declare no competing interests.
